KMTS
KESTRA MEDICAL (KMTS)
NASDAQ
$20.75+$0.02 (+0.10%)
Price as of Jun 23, 2026 4:45 PM EDT
  • $1.2B
    Market Cap
  • 29.56%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
04/30/2025
Income Statement
Total Operating Revenue
59.8M
N/A
Cost of Revenue
35.6M
N/A
Gross Profit
24.2M
N/A
Sales and Marketing Expense
114.9M
N/A
Research and Development Expense
-15.7M
N/A
Depreciation and Amortization Expense
8.0M
N/A
Total Operating Expenses
130.6M
N/A
Operating Profit
-106.4M
N/A
Interest Income
3.2M
N/A
Interest Expense
N/A
N/A
Interest Income and Expense and Net
3.2M
N/A
Total Nonoperating Income and Expense
-2.8M
N/A
Income before Taxes
-113.7M
N/A
Income Taxes
135,000
N/A
Extraordinary Items
0
N/A
Net Income
-113.8M
N/A
Net Income from Continuing Operations Applicable to Common
-126.1M
N/A
Basic EPS and Net Income
-5.13
N/A
Diluted EPS and Net Income
-5.13
N/A
Basic Weighted Average Shares
24.6M
N/A
Diluted Weighted Average Shares
24.6M
N/A
Balance Sheet
Cash and Cash Equivalents
237.6M
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
237.6M
N/A
Total Current Assets
255.3M
N/A
Accumulated Depreciation
24.0M
N/A
Property and Plant and Equipment and Net
34.8M
N/A
Total Long-Term Assets
1.2M
N/A
Total Assets
295.7M
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
N/A
N/A
Total Current Liabilities
38.0M
N/A
Total Long-Term Debt
41.1M
N/A
Total Long-Term Liabilities
140,000
N/A
Total Liabilities
90.3M
N/A
Retained Earnings
-520.2M
N/A
Total Stockholders Equity
205.4M
N/A
Total Shares Outstanding
51.3M
N/A
Cash Flow
Cash from Operating Activities
-77.6M
N/A
Capital Expenditures
22.9M
N/A
Cash from Investing Activities
-23.3M
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
330.3M
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow